Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Celecoxib-induced bullous fixed drug eruption: An unusual presentation.

Ammar H, Ben Fredj N, Ben Fadhel N, Chadli Z, Ben Romdhane H, Boughattas NA, Chaabane A, Aouam K.

Br J Clin Pharmacol. 2019 Nov;85(11):2638-2639. doi: 10.1111/bcp.14072. Epub 2019 Aug 2. No abstract available.

PMID:
31376180
2.

Clinical features, culprit drugs, and allergology workup in 41 cases of fixed drug eruption.

Ben Fadhel N, Chaabane A, Ammar H, Ben Romdhane H, Soua Y, Chadli Z, Zili J, Boughattas NA, Ben Fredj N, Aouam K.

Contact Dermatitis. 2019 Nov;81(5):336-340. doi: 10.1111/cod.13351. Epub 2019 Aug 7.

PMID:
31291002
3.

Exanthema following a spider bite mimicking baboon syndrome.

Lahouel I, Kenani Z, Belhadjali H, Soua Y, Korbi M, Youssef M, Aouam K, Zili J.

Contact Dermatitis. 2019 Oct;81(4):309-311. doi: 10.1111/cod.13300. Epub 2019 May 27. No abstract available.

PMID:
31056766
4.

Drug Rash with Eosinophilia and Systemic Symptoms: Captropril, an Unusual Culprit Drug.

Ammar H, Chaabane A, Ben Fadhel N, Chadli Z, Ben Fredj N, Aouam K.

Dermatitis. 2019 May/Jun;30(3):238-239. doi: 10.1097/DER.0000000000000464. No abstract available.

PMID:
31045940
5.

Piroxicam-induced fixed drug eruption: Cross-reactivity with meloxicam.

Ben Romdhane H, Ammar H, Ben Fadhel N, Chadli Z, Ben Fredj N, Boughattas NA, Chaabane A, Aouam K.

Contact Dermatitis. 2019 Jul;81(1):24-26. doi: 10.1111/cod.13225. Epub 2019 Mar 4.

PMID:
30663057
6.

Interest of therapeutic drug monitoring of aminoglycosides administered by a monodose regimen.

Ben Romdhane H, Ben Fredj N, Chaabane A, Ben Aicha S, Chadly Z, Ben Fadhel N, Boughattas N, Aouam K.

Nephrol Ther. 2019 Apr;15(2):110-114. doi: 10.1016/j.nephro.2018.08.004. Epub 2019 Jan 16.

PMID:
30660586
7.

Meglumine antimoniate-induced DRESS: original case with a positive skin test.

Chaabane A, Romdhane HB, Brahim HB, Fredj NB, Chadli Z, Boughattas NA, Chakroun M, Aouam K.

Acta Parasitol. 2018 Dec 19;63(4):845-847. doi: 10.1515/ap-2018-0104.

PMID:
30367758
8.

Distribution of Genetic Polymorphisms of Genes Implicated in Thiopurine Drugs Metabolism.

Chadli Z, Kerkeni E, Hannachi I, Chouchene S, Ben Fredj N, Boughattas NA, Aouam K, Chaabane A.

Ther Drug Monit. 2018 Oct;40(5):655-659. doi: 10.1097/FTD.0000000000000548.

PMID:
30086084
9.

Codeine-induced acute generalized exanthematous pustulosis without IL36RN mutations.

Chadli Z, Ladhari C, Kerkeni E, Djobbi A, Fredj NB, Chaabane A, Boughattas NA, Aouam K.

Pharmacogenomics. 2018 Jul 1;19(11):889-893. doi: 10.2217/pgs-2017-0200. Epub 2018 Jun 19.

PMID:
29914290
10.

Glibenclamide-induced photodistributed lichenoid eruption: An unusual association.

Chadli Z, Chaabane A, Ben Fadhl N, Fredj NB, Boughattas NA, Aouam K.

Therapie. 2018 Oct;73(5):429-431. doi: 10.1016/j.therap.2018.01.008. Epub 2018 May 24. No abstract available.

PMID:
29803511
11.

Association of non-immediate drug hypersensitivity with drug exposure: A case control analysis of spontaneous reports from a Tunisian pharmacovigilance database.

Chaabane A, Fadhel NB, Chadli Z, Romdhane HB, Fredj NB, Boughattas NA, Aouam K.

Eur J Intern Med. 2018 Jul;53:40-44. doi: 10.1016/j.ejim.2018.01.032. Epub 2018 Mar 2.

PMID:
29409745
12.

Teicoplanin-induced DRESS syndrome: The importance of skin tests.

Ben Romdhane H, Chadli Z, Ben Fredj N, Chaabane A, Boughattas NA, Aouam K.

Med Mal Infect. 2018 Jun;48(4):291-293. doi: 10.1016/j.medmal.2018.01.002. Epub 2018 Feb 1. No abstract available.

PMID:
29395498
13.

Is p-phenylenediamine a marker of sulfasalazine allergy?

Kenani Z, Lahouel I, Belhadjali H, Soua Y, Aouam K, Youssef M, Zili J.

Contact Dermatitis. 2018 Feb;78(2):173-174. doi: 10.1111/cod.12885. No abstract available.

PMID:
29341189
14.

Therapeutic drug monitoring of caffeine in preterm infants: Could saliva be an alternative to serum?

Chaabane A, Chioukh FZ, Chadli Z, Ben Fredj N, Ben Ameur K, Ben Hmida H, Boughattas NA, Monastiri K, Aouam K.

Therapie. 2017 Dec;72(6):685-689. doi: 10.1016/j.therap.2017.06.004. Epub 2017 Jul 29.

PMID:
28964570
15.

Circadian variation in anticonvulsant activity of valproic acid in mice.

Khedhaier WBC, Dridi I, Aouam K, Ben-Attia M, Reinberg A, Boughattas NA.

Biomed Pharmacother. 2017 Nov;95:25-30. doi: 10.1016/j.biopha.2017.08.047. Epub 2017 Aug 18.

PMID:
28826093
16.

Dosing-time dependent oxidative effects of an immunosuppressive drug "Mycophenolate Mofetil" on rat kidneys.

Dridi I, Ben-Cherif W, Chahdoura H, Haouas Z, Ben-Attia M, Aouam K, Reinberg A, Boughattas NA.

Biomed Pharmacother. 2017 Mar;87:509-518. doi: 10.1016/j.biopha.2016.12.087. Epub 2017 Jan 8.

PMID:
28076831
17.

Circadian variation of isoniazid pharmacokinetics in mice.

Souayed N, Chennoufi M, Frej NB, Chaabane A, Ben-Attia M, Aouam K, Reinberg A, Boughattas NA.

Biomed Pharmacother. 2016 Dec;84:1150-1155. doi: 10.1016/j.biopha.2016.10.054. Epub 2016 Oct 22.

PMID:
27780145
18.

Modeling of Tacrolimus Exposure in Kidney Transplant According to Posttransplant Time Based on Routine Trough Concentration Data.

Ben Fredj N, Woillard JB, Debord J, Chaabane A, Boughattas N, Marquet P, Saint-Marcoux F, Aouam K.

Exp Clin Transplant. 2016 Aug;14(4):394-400.

19.

Circadian variation of cytotoxicity and genotoxicity induced by an immunosuppressive agent "Mycophenolate Mofetil" in rats.

Dridi I, Grissa I, Ezzi L, Chakroun S, Ben-Cherif W, Haouas Z, Aouam K, Ben-Attia M, Reinberg A, Boughattas NA.

Chronobiol Int. 2016;33(9):1208-1221. Epub 2016 Aug 2.

PMID:
27484793
20.

Risk factors of isoniazid-induced hepatotoxicity in Tunisian tuberculosis patients.

Ben Fredj N, Gam R, Kerkni E, Chaabane A, Chadly Z, Boughattas N, Aouam K.

Pharmacogenomics J. 2017 Jul;17(4):372-377. doi: 10.1038/tpj.2016.26. Epub 2016 Apr 19.

PMID:
27089936
21.

Influence of combined CYP3A4 and CYP3A5 single-nucleotide polymorphisms on tacrolimus exposure in kidney transplant recipients: a study according to the post-transplant phase.

Aouam K, Kolsi A, Kerkeni E, Ben Fredj N, Chaabane A, Monastiri K, Boughattas N.

Pharmacogenomics. 2015 Dec;16(18):2045-54. doi: 10.2217/pgs.15.138. Epub 2015 Nov 30.

PMID:
26615671
22.

Colloidal silica-induced hypersensitivity: myth or reality.

Ben Fredj N, Ben Fadhel N, Chaabane A, Chadly Z, Ben Romdhane H, Boughattas A, Aouam K.

Int J Clin Pharm. 2016 Feb;38(1):7-9. doi: 10.1007/s11096-015-0225-x. Epub 2015 Nov 27.

PMID:
26613737
23.

The rest of the story of the patient described in the letter to the editors: 'Hypersensitivity to amoxicillin after… (DRESS) to carbamazepine…: a possible co-sensitization'.

Chadli Z, Ben Fredj N, Youssef M, Chaabane A, Boughattas NA, Zili JE, Aouam K.

Br J Clin Pharmacol. 2016 Apr;81(4):784-5. doi: 10.1111/bcp.12823. Epub 2016 Jan 8. No abstract available.

24.

Gastrointestinal toxicity of mycophenolate mofetil in rats: Effect of administration time.

Dridi I, Ben-Cherif W, Haouas Z, Aouam K, Ben-Attia M, Reinberg A, Boughattas NA.

Chronobiol Int. 2015;32(10):1373-84. doi: 10.3109/07420528.2015.1082481. Epub 2015 Nov 9.

PMID:
26554521
25.

Circadian variation in murine hepatotoxicity to the antituberculosis agent «Isoniazide».

Souayed N, Chennoufi M, Boughattas F, Haouas Z, Maaroufi K, Miled A, Ben-Attia M, Aouam K, Reinberg A, Boughattas NA.

Chronobiol Int. 2015;32(9):1201-10. doi: 10.3109/07420528.2015.1078808. Epub 2015 Oct 19.

PMID:
26479844
26.

Circadian-time dependent tolerance and haematological toxicity to isoniazid in murine.

Souayed N, Chennoufi M, Boughattas F, Hassine M, Ben Attia M, Aouam K, Reinberg A, Boughattas NA.

Biomed Pharmacother. 2015 Apr;71:233-9. doi: 10.1016/j.biopha.2015.02.026. Epub 2015 Mar 3.

PMID:
25960242
27.

Development of Limited Sampling Strategies for the Estimation of Tacrolimus Area Under the Curve in Adult Kidney Transplant Recipients According to the Posttransplantation Time.

Aouam K, Chadli Z, Hammouda M, Fredj NB, Aloui S, May ME, Boughattas N, Skhiri H, Chaabane A.

Ther Drug Monit. 2015 Aug;37(4):524-30. doi: 10.1097/FTD.0000000000000173.

PMID:
25627405
28.

Phenobarbital-induced DRESS: a lichenoïd picture.

Chaabane A, Ben Fadhel N, Chadli Z, Ben Fredj N, Boughattas NA, Aouam K.

Iran J Allergy Asthma Immunol. 2014 Dec;13(6):453-5.

29.

A patch test confirmed phenobarbital-induced fixed drug eruption in a child.

Chadly Z, Aouam K, Chaabane A, Belhadjali H, Abderrazzak Boughattas N, Zili JE.

Iran J Allergy Asthma Immunol. 2014 Jun;13(3):214-7.

30.

Circadian variation of mycophenolate mofetil pharmacokinetics in rats.

Dridi I, Ben-Cherif W, Aouam K, Ben-Attia M, Klouz A, Reinberg A, Boughattas NA.

Eur J Pharm Sci. 2014 Jul 16;58:20-5. doi: 10.1016/j.ejps.2014.02.015. Epub 2014 Mar 19.

PMID:
24657835
31.

Albendazole-induced associated acute hepatitis and bicytopenia.

Ben Fredj N, Chaabane A, Chadly Z, Ben Fadhel N, Boughattas NA, Aouam K.

Scand J Infect Dis. 2014 Feb;46(2):149-51. doi: 10.3109/00365548.2013.835068.

PMID:
24423162
32.

Captopril-induced DRESS: first reported case confirmed by patch test.

Chaabane A, Fadhl NB, Chadly Z, Fredj NB, Boughattas NA, Aouam K.

Dermatitis. 2013 Sep-Oct;24(5):255-7. doi: 10.1097/DER.0b013e3182a5d86d. No abstract available.

PMID:
24030372
33.

Fixed drug eruption: a selective reaction to amoxicillin.

Chaabane A, Fredj NB, Chadly Z, Boughattas NA, Aouam K.

Therapie. 2013 May-Jun;68(3):183-5. doi: 10.2515/therapie/2013027. Epub 2013 Jul 26. No abstract available.

PMID:
23886467
34.

Limited sampling strategy of mycophenolic acid in adult kidney transplant recipients: influence of the post-transplant period and the pharmacokinetic profile.

Chaabane A, Aouam K, Ben Fredj N, Hammouda M, Chadly Z, El May M, Boughattas N, Skhiri H.

J Clin Pharmacol. 2013 Sep;53(9):925-33. doi: 10.1002/jcph.125. Epub 2013 Jun 27.

PMID:
23813362
35.

Circadian variation of Valproic acid pharmacokinetics in mice.

Ben-Cherif W, Dridi I, Aouam K, Ben-Attia M, Reinberg A, Boughattas NA.

Eur J Pharm Sci. 2013 Jul 16;49(4):468-73. doi: 10.1016/j.ejps.2013.05.009. Epub 2013 May 23.

PMID:
23707469
36.

Tacrolimus therapeutic drug monitoring in Tunisian renal transplant recipients: effect of post-transplantation period.

Ben Fredj N, Chaabane A, Chadly Z, Hammouda M, Aloui S, Boughattas NA, Skhiri H, Aouam K.

Transpl Immunol. 2013 Jun;28(4):198-202. doi: 10.1016/j.trim.2013.04.003. Epub 2013 Apr 20.

PMID:
23608723
37.

Chronotolerance study of the antiepileptic drug valproic acid in mice.

Ben-Cherif W, Dridi I, Aouam K, Ben-Attia M, Reinberg A, Boughattas NA.

J Circadian Rhythms. 2012 May 10;10:3. doi: 10.1186/1740-3391-10-3.

38.

Severe ranitidine-induced anaphylaxis: a case report and literature review.

Aouam K, Bouida W, Ben Fredj N, Chaabane A, Boubaker H, Boukef R, Boughattas NA, Nouira S.

J Clin Pharm Ther. 2012 Aug;37(4):494-6. doi: 10.1111/j.1365-2710.2011.01320.x. Epub 2011 Nov 7. Review.

PMID:
22059646
39.

Delayed cross-reactivity between cyclophosphamide and chlorambucil.

Ben Fredj N, Aouam K, Chaabane A, Njim L, Boughattas N.

J Clin Pharmacol. 2012 May;52(5):771-4. doi: 10.1177/0091270011405056. Epub 2011 Sep 28. No abstract available.

PMID:
21956606
40.

Fixed drug eruption: levofloxacin, another culprit drug.

Ben Fredj N, Aouam K, Chaabane A, Braham D, Boughattas NA.

J Clin Pharmacol. 2012 May;52(5):775-7. doi: 10.1177/0091270011405501. Epub 2011 Sep 27. No abstract available.

PMID:
21953574
41.

[H1N1 influenza vaccines in Tunisia: efficiency and safety].

Chaabane A, Aouam K, Ben Fredj N, Toumi A, Braham D, A Boughattas N, Chakroun M.

Therapie. 2011 May-Jun;66(3):281-9. doi: 10.2515/therapie/2011028. Epub 2011 Aug 9. French.

PMID:
21819811
42.

Drug rash with eosinophilia and systemic symptoms (DRESS) probably induced by cefotaxime: a report of two cases.

Aouam K, Chaabane A, Toumi A, Ben Fredj N, Ben Romdhane F, Boughattas NA, Chakroun M.

Clin Med Res. 2012 Feb;10(1):32-5. doi: 10.3121/cmr.2011.995. Epub 2011 Aug 4.

43.

Les vaccins anti A(H1N1) en Tunisie : efficacité et tolérance.

Chaabane A, Aouam K, Fredj NB, Toumi A, Braham D, Boughattas NA, Chakroun M.

Therapie. 2011 May-Jun;66(3):281-9. doi: 10.2515/therapie/2011028. French.

PMID:
27393205
44.

Human intravenous immunoglobulin-induced aseptic meningitis: a case report.

Chaabane A, Hamzaoui A, Aouam K, Klai R, Fredj NB, Boughattas NA, Mahjoub S.

J Clin Pharmacol. 2012 Feb;52(2):279-81. doi: 10.1177/0091270010394183. No abstract available.

PMID:
21257801
45.

[DRESS syndrome: 11 case reports and a literature review].

Chaabane A, Aouam K, Ben Fredj N, A Boughattas N.

Therapie. 2010 Nov-Dec;65(6):543-50. Epub 2010 Dec 23. French.

PMID:
21176761
46.

[Safety of rheumatic disease drugs at childbearing age].

Zrour-Hassen S, Jguirim M, Aouam K, Korbaa W, Younes M, Bejia I, Touzi M, Bergaoui N.

Therapie. 2010 Sep-Oct;65(5):465-73. doi: 10.2515/therapie/2010061. Epub 2010 Dec 13. Review. French.

PMID:
21144482
47.

DRESS syndrome : étude de 11 cas et revue de la littérature.

Chaabane A, Aouam K, Fredj NB, Boughattas NA.

Therapie. 2010 Nov-Dec;65(6):543-50. doi: 10.2515/therapie/2010072. French.

PMID:
27393273
48.

Hypersensitivity to amoxicillin after drug rash with eosinophilia and systemic symptoms (DRESS) to carbamazepine and allopurinol: a possible co-sensitization.

Ben Fredj N, Aouam K, Chaabane A, Toumi A, Ben Rhomdhane F, Boughattas N, Chakroun M.

Br J Clin Pharmacol. 2010 Aug;70(2):273-6. doi: 10.1111/j.1365-2125.2010.03685.x. No abstract available.

49.

Amoxicillin-Induced Hypersensitivity After DRESS To Carbamazepine.

Aouam K, Fredj Nadia B, Amel C, Naceur B.

World Allergy Organ J. 2010 Jul;3(7):220-2. doi: 10.1097/WOX.0b013e3181eab930.

50.

Lichenoid eruption associated with hydrochlorothiazide and possible cross reactivity to furosemide.

Aouam K, Ali HB, Youssef M, Chaabane A, Hamdi MH, Boughattas NA, Zili JE.

Therapie. 2009 Sep-Oct;64(5):344-7. No abstract available.

PMID:
20108448

Supplemental Content

Support Center